A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Cohen, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 48263
Los Angeles, California, United States
- Site Reference Id/investigator# 48264
Aurora, Colorado, United States
- Site Reference Id/investigator# 51282
Gainesville, Florida, United States
- Site Reference Id/investigator# 50425
Springfield, Massachusetts, United States
- Site Reference Id/investigator# 50423
Kansas City, Missouri, United States
- Site Reference Id/investigator# 48268
New York, New York, United States
- Site Reference Id/investigator# 50428
Statesville, North Carolina, United States
- Site Reference Id/investigator# 48266
San Antonio, Texas, United States
- Site Reference Id/investigator# 50427
Newport News, Virginia, United States
- Site Reference Id/investigator# 48265
Seattle, Washington, United States
- Site Reference Id/investigator# 50424
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 30 Nov 2011
- Completion
- 31 Oct 2012
- Last update posted
- 8 Jan 2015
- Registered enrollment
- 50
- Registry id
- NCT01306617
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.